FILE – In this March 16, 2020, file photo, a subject gets a shot in the first-stage safety research study of a possible vaccine for COVID-19 A various COVID vaccine will be tested in August at the University of Alabama at Birmingham. (AP Photo/Ted S. Warren, File) AP
Researchers at the University of Alabama at Birmingham are searching for approximately 500 individuals to take part in a scientific trial of an appealing vaccine for the infection that causes COVID-19
UAB Medical facility announced this week that it will start human trials next month on a vaccine being established by researchers at Oxford University and AstraZeneca. The new trial is different from earlier studies that have been conducted at UAB on possible vaccines and treatments for the SARS-CoV-2 virus.
A research study published earlier this week revealed the brand-new vaccine had produced an appealing immune response in a minimal number of subjects in early trials and now the scientists are stepping up their efforts to figure out whether the vaccine is safe and efficient in a larger population.
” The study will enroll 30,000 individuals nationwide, or 33,000, and we are going to vaccinate at least 500 individuals in your area,” stated Dr. Paul Goepfert, a UAB scientist who is looking to register clients in the study locally. “And we’ll see how that goes in terms of numbers that will we can enlist.”
Goepfert stated the vaccine is given up two doses, about a month apart. The procedure calls for a 2-to-1 ratio of vaccine to manage clients, so for every two individuals who receives the vaccine, one will be given a placebo. Goepfert said the medical professionals and patients likely will not know whether they rece